Credit Suisse Ag Lowers stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Credit Suisse Ag reduced its stake in UnitedHealth Group Inc by 0.25% during the most recent quarter end. The investment management company now holds a total of 10,523,146 shares of UnitedHealth Group Inc which is valued at $1,503,547,100 after selling 26,528 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Aug 11, 2016.UnitedHealth Group Inc makes up approximately 1.85% of Credit Suisse Ag’s portfolio.

Other Hedge Funds, Including , Logan Capital Management Inc reduced its stake in UNH by selling 1,442 shares or 49.72% in the most recent quarter. The Hedge Fund company now holds 1,458 shares of UNH which is valued at $208,319. UnitedHealth Group Inc makes up approx 0.02% of Logan Capital Management Inc’s portfolio.Pegasus Partners Ltd. boosted its stake in UNH in the latest quarter, The investment management firm added 876 additional shares and now holds a total of 12,696 shares of UnitedHealth Group Inc which is valued at $1,810,830. UnitedHealth Group Inc makes up approx 0.90% of Pegasus Partners Ltd.’s portfolio.Mckinley Carter Wealth Services boosted its stake in UNH in the latest quarter, The investment management firm added 956 additional shares and now holds a total of 15,693 shares of UnitedHealth Group Inc which is valued at $2,242,216. UnitedHealth Group Inc makes up approx 1.14% of Mckinley Carter Wealth Services’s portfolio.Cedar Hill Associates reduced its stake in UNH by selling 2,005 shares or 1.68% in the most recent quarter. The Hedge Fund company now holds 117,058 shares of UNH which is valued at $16,475,914. UnitedHealth Group Inc makes up approx 2.75% of Cedar Hill Associates’s portfolio.

UnitedHealth Group Inc closed down -0.08 points or -0.06% at $142.01 with 22,95,478 shares getting traded on Tuesday. Post opening the session at $142.73, the shares hit an intraday low of $141.75 and an intraday high of $142.87 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.

Investors should note that on Aug 3, 2016, UnitedHealth Group Inc announced a cash dividend of $0.6250. The company’s management has announced Sep 7, 2016 as the ex-dividend date and fixed the record date on Sep 9, 2016. The payable date has been fixed on Sep 20, 2016.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *